UBS Group AG

Position in NVCT — Nuvectis Pharma, Inc.

CIK 1610520 ZURICH, V8

Position in NVCT

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$298,091

+$234,860 QoQ

Shares Held

38,563

+360.5% QoQ

Ownership

0.145%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. NVCT ranks #316 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$298,091	38,563	+360.5%	Shares	Defined	2026-05-05
2025-12-31	$63,231	8,375	-67.1%	Shares	Defined	2026-01-29
2025-09-30	$153,323	25,469	+148.3%	Shares	Defined	2025-11-13
2025-06-30	$76,626	10,258	-90.8%	Shares	Defined	2025-08-14
2025-03-31	$1,089,550	111,520	+4078.3%	Shares	Defined	2025-05-13
2024-12-31	$14,438	2,669	+24163.6%	Shares	Defined	2025-02-14
2024-09-30	$69	11	-15.4%	Shares	Sole	2024-11-14
2024-06-30	$82	13	-99.8%	Shares	Sole	2024-08-14
2024-03-31	$62,483	7,620	-5.5%	Shares	Defined	2024-05-13
2023-12-31	$67,220	8,060	+113.5%	Shares	Sole	2024-02-09
2023-09-30	$48,672	3,776	-5.1%	Shares	Sole	2023-11-09
2023-06-30	$63,544	3,979	+1708.6%	Shares	Sole	2023-08-11
2022-09-30	$1,559	220	+254.8%	Shares	Sole	2022-11-10
2022-06-30	$694	62	-56.0%	Shares	Sole	2022-08-10
2022-03-31	$1,044	141	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.